According to Market IntelliX Research, the global market for VMAT2 Inhibitors should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China VMAT2 Inhibitors market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States VMAT2 Inhibitors market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Tetrabenazine segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Huntington’s Disease has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of VMAT2 Inhibitors include Neurocrine Biosciences, Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Hikma Pharmaceuticals plc, Hetero, Bausch Health Companies Inc, Dr. Reddy's Laboratories Ltd, Piramal Pharma Solution and Lupin, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

Vesicular monoamine transporter-2 is the transmembrane protein which is primarily responsible for the transport of monoamines neurotransmitters such as histamines, serotonin, dopamine, and norepinephrine into the synaptic vesicles. VMAT2 transporter carries the cytoplasmic dopamine into the vesicles. VMAT2 inhibitors reduce the dopamine at the presynaptic striatal nerve terminals and decrease unwanted body movements for these conditions. VMAT2 inhibitors are widely used to treat uncontrollable involuntary, repetitive body movements caused by tardive dyskinesia and Huntington’s disease.

This report aims to provide a comprehensive study of the global market for VMAT2 Inhibitors. Report Highlights:

(1) Global VMAT2 Inhibitors market size (sales volume & revenue),history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global VMAT2 Inhibitors market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China VMAT2 Inhibitors market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global VMAT2 Inhibitors segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global VMAT2 Inhibitors segment by type and by application and regional segment by type and by application.

(6) Global major production regions of VMAT2 Inhibitors, capacity, production and trends.

(7) VMAT2 Inhibitors industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Tetrabenazine

Valbenazine

Other

Market segment by application, can be divided into

Huntington’s Disease

Tardive Dyskinesia

Other

Market segment by players, this report covers

Neurocrine Biosciences, Inc

Teva Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

Hikma Pharmaceuticals plc

Hetero

Bausch Health Companies Inc

Dr. Reddy's Laboratories Ltd

Piramal Pharma Solution

Lupin

Luye Pharma Group

1 Market Overview

1.1 VMAT2 Inhibitors Definition

1.2 Global VMAT2 Inhibitors Market Size and Forecast

1.2.1 By Revenue, Global VMAT2 Inhibitors Market Size, 2019-2030

1.2.2 By Sales Volume, Global VMAT2 Inhibitors Market Size, 2019-2030

1.2.3 Global VMAT2 Inhibitors Price Trend, 2019-2030

1.3 China VMAT2 Inhibitors Market Size and Forecast

1.3.1 By Revenue, China VMAT2 Inhibitors Market Size, 2019-2030

1.3.2 By Sales Volume, China VMAT2 Inhibitors Market Size, 2019-2030

1.3.3 China VMAT2 Inhibitors Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China VMAT2 Inhibitors Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China VMAT2 Inhibitors Share in Global Market, 2019-2030

1.4.3 VMAT2 Inhibitors Market Size: China VS Global, 2019-2030

1.5 VMAT2 Inhibitors Market Dynamics

1.5.1 VMAT2 Inhibitors Market Drivers

1.5.2 VMAT2 Inhibitors Market Restraints

1.5.3 VMAT2 Inhibitors Industry Trends

1.5.4 VMAT2 Inhibitors Industry Policy

2 Global Competitive Landscape by Company

2.1 Global VMAT2 Inhibitors Revenue by Company, 2019-2024

2.2 Global VMAT2 Inhibitors Sales Volume by Company, 2019-2024

2.3 Global VMAT2 Inhibitors Price by Company, 2019-2024

2.4 Global VMAT2 Inhibitors Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global VMAT2 Inhibitors Concentration Ratio

2.6 Global VMAT2 Inhibitors Mergers & Acquisitions, Expansion Plans

2.7 Global VMAT2 Inhibitors Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China VMAT2 Inhibitors Revenue by Company, 2019-2024

3.2 China VMAT2 Inhibitors Sales Volume by Company, 2019-2024

3.3 China VMAT2 Inhibitors VMAT2 Inhibitors Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China VMAT2 Inhibitors Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, VMAT2 Inhibitors Domestic VS Export

3.6 China Market, VMAT2 Inhibitors Import & Export

3.6.1 China Market, VMAT2 Inhibitors Import & Export, 2019-2030

3.6.2 China VMAT2 Inhibitors Import & Export Trends

3.6.3 Main Sources of China VMAT2 Inhibitors Import

3.6.4 Export Destination of China VMAT2 Inhibitors

4 VMAT2 Inhibitors Production by Region

4.1 Global VMAT2 Inhibitors Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of VMAT2 Inhibitors Manufacturers

4.3 Global Major Manufacturers, VMAT2 Inhibitors Capacity Expansion and Future Plans

4.4 Global VMAT2 Inhibitors Capacity by Region

4.5 Global VMAT2 Inhibitors Production by Region

4.5.1 Global VMAT2 Inhibitors Production & Forecast by Region, 2019 VS 2024 VS 2030

4.5.2 Global VMAT2 Inhibitors Production by Region, 2019-2024

4.5.3 Global VMAT2 Inhibitors Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 VMAT2 Inhibitors Industry Chain

5.2 VMAT2 Inhibitors Upstream Analysis

5.2.1 VMAT2 Inhibitors Core Raw Materials

5.2.2 Main Manufacturers of VMAT2 Inhibitors Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 VMAT2 Inhibitors Production Mode

5.6 VMAT2 Inhibitors Procurement Model

5.7 VMAT2 Inhibitors Industry Sales Model and Sales Channels

5.7.1 VMAT2 Inhibitors Sales Model

5.7.2 VMAT2 Inhibitors Typical Distributors

6 Sights by Type

6.1 VMAT2 Inhibitors Classification

6.1.1 Tetrabenazine

6.1.2 Valbenazine

6.1.3 Other

6.2 By Type, Global VMAT2 Inhibitors Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global VMAT2 Inhibitors Revenue, 2019-2030

6.4 By Type, Global VMAT2 Inhibitors Sales Volume, 2019-2030

6.5 By Type, Global VMAT2 Inhibitors Price, 2019-2030

7 Sights by Application

7.1 VMAT2 Inhibitors Segment by Application

7.1.1 Huntington’s Disease

7.1.2 Tardive Dyskinesia

7.1.3 Other

7.2 By Application, Global VMAT2 Inhibitors Market Size & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global VMAT2 Inhibitors Revenue, 2019-2030

7.4 By Application, Global VMAT2 Inhibitors Sales Volume, 2019-2030

7.5 By Application, Global VMAT2 Inhibitors Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global VMAT2 Inhibitors Market Size, 2019 VS 2024 VS 2030

8.2 By Region, Global VMAT2 Inhibitors Revenue, 2019-2030

8.3 By Region, Global VMAT2 Inhibitors Sales Volume, 2019-2030

8.4 North America

8.4.1 North America VMAT2 Inhibitors Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America VMAT2 Inhibitors Market Size Market Share

8.5 Europe

8.5.1 Europe VMAT2 Inhibitors Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe VMAT2 Inhibitors Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific VMAT2 Inhibitors Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific VMAT2 Inhibitors Market Size Market Share

8.7 South America

8.7.1 South America VMAT2 Inhibitors Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America VMAT2 Inhibitors Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global VMAT2 Inhibitors Market Size & CAGR，2019 VS 2024 VS 2030

9.2 By Country, Global VMAT2 Inhibitors Revenue, 2019-2030

9.3 By Country, Global VMAT2 Inhibitors Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. VMAT2 Inhibitors Market Size, 2019-2030

9.4.2 By Company, U.S. VMAT2 Inhibitors Sales Volume Market Share, 2023

9.4.3 By Type, U.S. VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.4.4 By Application, U.S. VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.5 Europe

9.5.1 Europe VMAT2 Inhibitors Market Size, 2019-2030

9.5.2 By Company, Europe VMAT2 Inhibitors Sales Volume Market Share, 2023

9.5.3 By Type, Europe VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.5.4 By Application, Europe VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.6 China

9.6.1 China VMAT2 Inhibitors Market Size, 2019-2030

9.6.2 By Company, China VMAT2 Inhibitors Sales Volume Market Share, 2023

9.6.3 By Type, China VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.6.4 By Application, China VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.7 Japan

9.7.1 Japan VMAT2 Inhibitors Market Size, 2019-2030

9.7.2 By Company, Japan VMAT2 Inhibitors Sales Volume Market Share, 2023

9.7.3 By Type, Japan VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.7.4 By Application, Japan VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.8 South Korea

9.8.1 South Korea VMAT2 Inhibitors Market Size, 2019-2030

9.8.2 By Company, South Korea VMAT2 Inhibitors Sales Volume Market Share, 2023

9.8.3 By Type, South Korea VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.8.4 By Application, South Korea VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia VMAT2 Inhibitors Market Size, 2019-2030

9.9.2 By Company, Southeast Asia VMAT2 Inhibitors Sales Volume Market Share, 2023

9.9.3 By Type, Southeast Asia VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.9.4 By Application, Southeast Asia VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.10 India

9.10.1 India VMAT2 Inhibitors Market Size, 2019-2030

9.10.2 By Company, India VMAT2 Inhibitors Sales Volume Market Share, 2023

9.10.3 By Type, India VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.10.4 By Application, India VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia VMAT2 Inhibitors Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia VMAT2 Inhibitors Sales Volume Market Share, 2023

9.11.3 By Type, Middle East & Asia VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

9.11.4 By Application, Middle East & Asia VMAT2 Inhibitors Market Size, Share, 2023 VS 2030

10 Manufacturers Profile

10.1 Neurocrine Biosciences, Inc

10.1.1 Neurocrine Biosciences, Inc Company Information, Head Office, Market Area and Industry Position

10.1.2 Neurocrine Biosciences, Inc VMAT2 Inhibitors Models, Specifications and Application

10.1.3 Neurocrine Biosciences, Inc VMAT2 Inhibitors Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Neurocrine Biosciences, Inc Company Profile and Main Business

10.1.5 Neurocrine Biosciences, Inc Recent Developments

10.2 Teva Pharmaceutical Industries Ltd

10.2.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

10.2.2 Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Models, Specifications and Application

10.2.3 Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business

10.2.5 Teva Pharmaceutical Industries Ltd Recent Developments

10.3 Sun Pharmaceutical Industries Ltd

10.3.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

10.3.2 Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Models, Specifications and Application

10.3.3 Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business

10.3.5 Sun Pharmaceutical Industries Ltd Recent Developments

10.4 Hikma Pharmaceuticals plc

10.4.1 Hikma Pharmaceuticals plc Company Information, Head Office, Market Area and Industry Position

10.4.2 Hikma Pharmaceuticals plc VMAT2 Inhibitors Models, Specifications and Application

10.4.3 Hikma Pharmaceuticals plc VMAT2 Inhibitors Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Hikma Pharmaceuticals plc Company Profile and Main Business

10.4.5 Hikma Pharmaceuticals plc Recent Developments

10.5 Hetero

10.5.1 Hetero Company Information, Head Office, Market Area and Industry Position

10.5.2 Hetero VMAT2 Inhibitors Models, Specifications and Application

10.5.3 Hetero VMAT2 Inhibitors Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Hetero Company Profile and Main Business

10.5.5 Hetero Recent Developments

10.6 Bausch Health Companies Inc

10.6.1 Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position

10.6.2 Bausch Health Companies Inc VMAT2 Inhibitors Models, Specifications and Application

10.6.3 Bausch Health Companies Inc VMAT2 Inhibitors Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Bausch Health Companies Inc Company Profile and Main Business

10.6.5 Bausch Health Companies Inc Recent Developments

10.7 Dr. Reddy's Laboratories Ltd

10.7.1 Dr. Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position

10.7.2 Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Models, Specifications and Application

10.7.3 Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Dr. Reddy's Laboratories Ltd Company Profile and Main Business

10.7.5 Dr. Reddy's Laboratories Ltd Recent Developments

10.8 Piramal Pharma Solution

10.8.1 Piramal Pharma Solution Company Information, Head Office, Market Area and Industry Position

10.8.2 Piramal Pharma Solution VMAT2 Inhibitors Models, Specifications and Application

10.8.3 Piramal Pharma Solution VMAT2 Inhibitors Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 Piramal Pharma Solution Company Profile and Main Business

10.8.5 Piramal Pharma Solution Recent Developments

10.9 Lupin

10.9.1 Lupin Company Information, Head Office, Market Area and Industry Position

10.9.2 Lupin VMAT2 Inhibitors Models, Specifications and Application

10.9.3 Lupin VMAT2 Inhibitors Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Lupin Company Profile and Main Business

10.9.5 Lupin Recent Developments

10.10 Luye Pharma Group

10.10.1 Luye Pharma Group Company Information, Head Office, Market Area and Industry Position

10.10.2 Luye Pharma Group VMAT2 Inhibitors Models, Specifications and Application

10.10.3 Luye Pharma Group VMAT2 Inhibitors Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.10.4 Luye Pharma Group Company Profile and Main Business

10.10.5 Luye Pharma Group Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. VMAT2 Inhibitors Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. VMAT2 Inhibitors Market Restraints

Table 3. VMAT2 Inhibitors Market Trends

Table 4. VMAT2 Inhibitors Industry Policy

Table 5. Global VMAT2 Inhibitors Revenue by Company, 2019-2024, US$ million

Table 6. Global VMAT2 Inhibitors Revenue Market Share by Company, 2019-2024

Table 7. Global VMAT2 Inhibitors Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global VMAT2 Inhibitors Sales Volume Market Share by Company, 2019-2024

Table 9. Global VMAT2 Inhibitors Price by Company, 2019-2024, (US$/Unit)

Table 10. Global VMAT2 Inhibitors Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global VMAT2 Inhibitors Mergers & Acquisitions, Expansion Plans

Table 12. Global VMAT2 Inhibitors Manufacturers Product Type

Table 13. China VMAT2 Inhibitors Revenue by Company, 2019-2024, US$ million

Table 14. China VMAT2 Inhibitors Revenue Market Share by Company, 2019-2024

Table 15. China VMAT2 Inhibitors Sales Volume by Company, 2019-2024, (K Units)

Table 16. China VMAT2 Inhibitors Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, VMAT2 Inhibitors Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China VMAT2 Inhibitors Import & Export Trends

Table 19. Main Sources of China VMAT2 Inhibitors Import

Table 20. Export Destination of China VMAT2 Inhibitors

Table 21. Global Headquarters and Manufacturing Base of VMAT2 Inhibitors Manufacturers

Table 22. Global Major Manufacturers, VMAT2 Inhibitors Capacity Expansion and Future Plans

Table 23. Global VMAT2 Inhibitors Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global VMAT2 Inhibitors Production by Region, 2019-2024, (K Units)

Table 25. Global VMAT2 Inhibitors Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of VMAT2 Inhibitors Upstream (Raw Materials)

Table 27. Global VMAT2 Inhibitors Typical Customers

Table 28. VMAT2 Inhibitors Typical Distributors

Table 29. By Type, Global VMAT2 Inhibitors Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global VMAT2 Inhibitors Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global VMAT2 Inhibitors Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global VMAT2 Inhibitors Revenue, 2019-2030, US$ Million

Table 33. By Region, Global VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global VMAT2 Inhibitors Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global VMAT2 Inhibitors Revenue, 2019-2030, US$ Million

Table 36. By Country, Global VMAT2 Inhibitors Revenue Market Share, 2019-2030

Table 37. By Country, Global VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global VMAT2 Inhibitors Sales Volume Market Share, 2019-2030

Table 39. Neurocrine Biosciences, Inc Company Information, Head Office, Market Area and Industry Position

Table 40. Neurocrine Biosciences, Inc VMAT2 Inhibitors Models, Specifications and Application

Table 41. Neurocrine Biosciences, Inc VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Neurocrine Biosciences, Inc Company Profile and Main Business

Table 43. Neurocrine Biosciences, Inc Recent Developments

Table 44. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 45. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Models, Specifications and Application

Table 46. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Teva Pharmaceutical Industries Ltd Company Profile and Main Business

Table 48. Teva Pharmaceutical Industries Ltd Recent Developments

Table 49. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 50. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Models, Specifications and Application

Table 51. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Sun Pharmaceutical Industries Ltd Company Profile and Main Business

Table 53. Sun Pharmaceutical Industries Ltd Recent Developments

Table 54. Hikma Pharmaceuticals plc Company Information, Head Office, Market Area and Industry Position

Table 55. Hikma Pharmaceuticals plc VMAT2 Inhibitors Models, Specifications and Application

Table 56. Hikma Pharmaceuticals plc VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Hikma Pharmaceuticals plc Company Profile and Main Business

Table 58. Hikma Pharmaceuticals plc Recent Developments

Table 59. Hetero Company Information, Head Office, Market Area and Industry Position

Table 60. Hetero VMAT2 Inhibitors Models, Specifications and Application

Table 61. Hetero VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Hetero Company Profile and Main Business

Table 63. Hetero Recent Developments

Table 64. Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position

Table 65. Bausch Health Companies Inc VMAT2 Inhibitors Models, Specifications and Application

Table 66. Bausch Health Companies Inc VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Bausch Health Companies Inc Company Profile and Main Business

Table 68. Bausch Health Companies Inc Recent Developments

Table 69. Dr. Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position

Table 70. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Models, Specifications and Application

Table 71. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Dr. Reddy's Laboratories Ltd Company Profile and Main Business

Table 73. Dr. Reddy's Laboratories Ltd Recent Developments

Table 74. Piramal Pharma Solution Company Information, Head Office, Market Area and Industry Position

Table 75. Piramal Pharma Solution VMAT2 Inhibitors Models, Specifications and Application

Table 76. Piramal Pharma Solution VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Piramal Pharma Solution Company Profile and Main Business

Table 78. Piramal Pharma Solution Recent Developments

Table 79. Lupin Company Information, Head Office, Market Area and Industry Position

Table 80. Lupin VMAT2 Inhibitors Models, Specifications and Application

Table 81. Lupin VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Lupin Company Profile and Main Business

Table 83. Lupin Recent Developments

Table 84. Luye Pharma Group Company Information, Head Office, Market Area and Industry Position

Table 85. Luye Pharma Group VMAT2 Inhibitors Models, Specifications and Application

Table 86. Luye Pharma Group VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Luye Pharma Group Company Profile and Main Business

Table 88. Luye Pharma Group Recent Developments

List of Figure

Figure 1. VMAT2 Inhibitors Picture

Figure 2. By Revenue, Global VMAT2 Inhibitors Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global VMAT2 Inhibitors Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global VMAT2 Inhibitors Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China VMAT2 Inhibitors Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China VMAT2 Inhibitors Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China VMAT2 Inhibitors Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China VMAT2 Inhibitors Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China VMAT2 Inhibitors Share of Global Market, 2019-2030

Figure 10. Global VMAT2 Inhibitors Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global VMAT2 Inhibitors Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China VMAT2 Inhibitors Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China VMAT2 Inhibitors Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China VMAT2 Inhibitors Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of VMAT2 Inhibitors Domestic VS Export, 2022

Figure 16. Global VMAT2 Inhibitors Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global VMAT2 Inhibitors Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global VMAT2 Inhibitors Production Market Share & Forecast by Region, 2019-2030

Figure 19. VMAT2 Inhibitors Industry Chain

Figure 20. VMAT2 Inhibitors Procurement Model

Figure 21. VMAT2 Inhibitors Sales Model

Figure 22. VMAT2 Inhibitors Sales Channels, Direct Sales and Distribution

Figure 23. Tetrabenazine

Figure 24. Valbenazine

Figure 25. Other

Figure 26. By Type, Global VMAT2 Inhibitors Revenue, 2019-2030, US$ Million

Figure 27. By Type, Global VMAT2 Inhibitors Revenue Market Share, 2019-2030

Figure 28. By Type, Global VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 29. By Type, Global VMAT2 Inhibitors Sales Volume Market Share, 2019-2030

Figure 30. By Type, Global VMAT2 Inhibitors Price, 2019-2030, (US$/Unit)

Figure 31. Huntington’s Disease

Figure 32. Tardive Dyskinesia

Figure 33. Other

Figure 34. By Application, Global VMAT2 Inhibitors Revenue, 2019-2030, US$ Million

Figure 35. By Application, Global VMAT2 Inhibitors Revenue Market Share, 2019-2030

Figure 36. By Application, Global VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 37. By Application, Global VMAT2 Inhibitors Sales Volume Market Share, 2019-2030

Figure 38. By Application, Global VMAT2 Inhibitors Price, 2019-2030, (US$/Unit)

Figure 39. By Region, Global VMAT2 Inhibitors Revenue Market Share, 2019-2030

Figure 40. By Region, Global VMAT2 Inhibitors Sales Volume Market Share, 2019-2030

Figure 41. North America VMAT2 Inhibitors Revenue & Forecasts, 2019-2030, US$ Million

Figure 42. By Country, North America VMAT2 Inhibitors Revenue Market Share, 2022

Figure 43. Europe VMAT2 Inhibitors Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, Europe VMAT2 Inhibitors Revenue Market Share, 2022

Figure 45. Asia Pacific VMAT2 Inhibitors Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country/Region, Asia Pacific VMAT2 Inhibitors Revenue Market Share, 2022

Figure 47. South America VMAT2 Inhibitors Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country, South America VMAT2 Inhibitors Revenue Market Share, 2022

Figure 49. Middle East & Africa VMAT2 Inhibitors Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. U.S. VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 51. By Company, U.S. VMAT2 Inhibitors Market Share, 2022

Figure 52. By Type, U.S. VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 53. By Application, U.S. VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 54. Europe VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 55. By Company, Europe VMAT2 Inhibitors Market Share, 2022

Figure 56. By Type, Europe VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 57. By Application, Europe VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 58. China VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 59. By Company, China VMAT2 Inhibitors Market Share, 2022

Figure 60. By Type, China VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 61. By Application, China VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 62. Japan VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 63. By Company, Japan VMAT2 Inhibitors Market Share, 2022

Figure 64. By Type, Japan VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 65. By Application, Japan VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 66. South Korea VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 67. By Company, South Korea VMAT2 Inhibitors Market Share, 2022

Figure 68. By Type, South Korea VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 69. By Application, South Korea VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 70. Southeast Asia VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 71. By Company, Southeast Asia VMAT2 Inhibitors Market Share, 2022

Figure 72. By Type, Southeast Asia VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 73. By Application, Southeast Asia VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 74. India VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 75. By Company, India VMAT2 Inhibitors Market Share, 2022

Figure 76. By Type, India VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 77. By Application, India VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 78. Middle East & Asia VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 79. By Company, Middle East & Asia VMAT2 Inhibitors Market Share, 2022

Figure 80. By Type, Middle East & Asia VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 81. By Application, Middle East & Asia VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 82. Research Methodology

Figure 83. Breakdown of Primary Interviews

Figure 84. Bottom-up Approaches

Figure 85. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)